|
US6891082B2
(en)
*
|
1997-08-01 |
2005-05-10 |
The Johns Hopkins University School Of Medicine |
Transgenic non-human animals expressing a truncated activintype II receptor
|
|
JP2001513982A
(ja)
|
1997-08-29 |
2001-09-11 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
フォリスタチン−3
|
|
US5942420A
(en)
|
1997-11-17 |
1999-08-24 |
Millennium Biotherapeutics, Inc. |
Molecules of the follistatin-related protein family and uses therefor
|
|
US7083791B2
(en)
|
1999-03-25 |
2006-08-01 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
US6797271B2
(en)
*
|
1999-03-25 |
2004-09-28 |
Genesis Research & Development Corporation Limited |
Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides
|
|
DE60117164T2
(de)
*
|
2000-11-07 |
2006-08-03 |
Immuno Vaccine Technologies Inc., Halifax |
Impfstoffe mit erhöhter immunantwort und verfahren zur deren herstellung
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
EP1401469A2
(en)
*
|
2001-04-09 |
2004-03-31 |
Lorantis Limited |
Therapeutic use and identification of modulators of a hedgehog signalling pathway or one of its target pathways
|
|
AUPR638101A0
(en)
*
|
2001-07-13 |
2001-08-09 |
Bioa Pty Limited |
Composition and method for treatment of disease
|
|
GB2385052A
(en)
*
|
2002-02-05 |
2003-08-13 |
Leuven K U Res & Dev |
Treatment of spondyloarthropathies
|
|
EP1572909A4
(en)
*
|
2002-02-21 |
2007-06-06 |
Wyeth Corp |
PROTEIN CONTAINING A DOMAINE OF FOLLISTATIN
|
|
BR0307871A
(pt)
*
|
2002-02-21 |
2005-04-12 |
Wyeth Corp |
Proteìnas contendo domìnio de folistatina
|
|
JP4257909B2
(ja)
*
|
2002-02-27 |
2009-04-30 |
サイエンスパーク株式会社 |
電子計算機のファイルシステムドライバの制御プログラム及びプログラムの記録媒体
|
|
AR047392A1
(es)
|
2002-10-22 |
2006-01-18 |
Wyeth Corp |
Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
|
|
JP2007524566A
(ja)
|
2002-12-20 |
2007-08-30 |
エンカム ファーマシューティカルズ アクティーゼルスカブ |
レセプターとリガンドの間の相互作用の調節の方法
|
|
AU2003901267A0
(en)
*
|
2003-03-19 |
2003-04-03 |
Monash University |
Assessment method
|
|
RU2322261C2
(ru)
*
|
2003-06-02 |
2008-04-20 |
Уайт |
Применение ингибиторов миостатика (gdf8) в сочетании с кортикостероидами для лечения нервно-мышечных заболеваний
|
|
WO2005032578A1
(en)
*
|
2003-10-06 |
2005-04-14 |
Monash University |
Therapeutic method
|
|
JP2008507288A
(ja)
*
|
2004-07-23 |
2008-03-13 |
アクセルロン ファーマ インコーポレーテッド |
ActRII受容体ポリペプチド、方法、および組成物
|
|
US20060257935A1
(en)
*
|
2005-04-26 |
2006-11-16 |
Ajinomoto Co., Inc. |
Hematopoietic factor production promoter
|
|
PL2407486T3
(pl)
|
2005-08-19 |
2018-05-30 |
Wyeth Llc |
Przeciwciała antagonistyczne względem GDF-8 i zastosowania w leczeniu ALS i innych zaburzeń związanych z GDF-8
|
|
CA2523032A1
(en)
|
2005-10-07 |
2007-04-07 |
Immunovaccine Technologies Inc. |
Vaccines for cancer therapy
|
|
ES2649983T3
(es)
|
2005-11-23 |
2018-01-16 |
Acceleron Pharma, Inc. |
Antagonistas de activina-ActRIIa en su uso para promover el crecimiento óseo
|
|
US8128933B2
(en)
|
2005-11-23 |
2012-03-06 |
Acceleron Pharma, Inc. |
Method of promoting bone growth by an anti-activin B antibody
|
|
US10835576B2
(en)
|
2006-05-18 |
2020-11-17 |
Myos Rens Technology Inc. |
Method of obtaining effective amounts of avian follistatin
|
|
US20070275036A1
(en)
|
2006-05-18 |
2007-11-29 |
Celldyne Biopharma, Llc |
Avian follistatin product
|
|
EP2097095B1
(en)
|
2006-11-29 |
2016-01-27 |
Nationwide Children's Hospital |
Myostatin inhibition for enhancing muscle and/or improving muscle function
|
|
US8895016B2
(en)
*
|
2006-12-18 |
2014-11-25 |
Acceleron Pharma, Inc. |
Antagonists of activin-actriia and uses for increasing red blood cell levels
|
|
MX2009008222A
(es)
*
|
2007-02-01 |
2009-10-12 |
Acceleron Pharma Inc |
Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama.
|
|
TW201803890A
(zh)
|
2007-02-02 |
2018-02-01 |
艾瑟勒朗法瑪公司 |
衍生自ActRIIB的變體與其用途
|
|
EA018221B1
(ru)
|
2007-02-09 |
2013-06-28 |
Акселерон Фарма Инк. |
АНТАГОНИСТЫ АКТИВИНА-ActRIIa И ПРИМЕНЕНИЕ ДЛЯ СТИМУЛЯЦИИ РОСТА КОСТИ У БОЛЬНЫХ РАКОМ
|
|
WO2009035629A1
(en)
*
|
2007-09-13 |
2009-03-19 |
Ludwig Institute Of Cancer Research |
Method for modifying cellular immune response by modulating activin activity
|
|
CN101861161B
(zh)
|
2007-09-18 |
2017-04-19 |
阿塞勒隆制药公司 |
活化素‑actriia拮抗剂和减少或抑制fsh分泌的用途
|
|
CN106310293A
(zh)
|
2007-09-27 |
2017-01-11 |
免疫疫苗技术有限公司 |
在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
|
|
US20100209452A1
(en)
*
|
2007-10-03 |
2010-08-19 |
Immunovaccine Technologies, Inc |
Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
|
|
WO2009146523A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Immunovaccine Technologies Inc. |
Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
|
|
CN102131822A
(zh)
|
2008-06-26 |
2011-07-20 |
阿塞勒隆制药公司 |
进行激活素-ActRIIa拮抗剂给药和监测受治疗患者的方法
|
|
DK2318028T3
(da)
*
|
2008-06-26 |
2020-05-04 |
Acceleron Pharma Inc |
Antagonister af opløselig activin-aktriia og anvendelser til øgning af røde blodcelleniveauer
|
|
TW201803586A
(zh)
|
2008-08-14 |
2018-02-01 |
艾瑟勒朗法瑪公司 |
使用gdf阱以增加紅血球水平
|
|
US8216997B2
(en)
|
2008-08-14 |
2012-07-10 |
Acceleron Pharma, Inc. |
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
|
|
AU2010204985A1
(en)
|
2009-01-13 |
2011-08-04 |
Acceleron Pharma Inc. |
Methods for increasing adiponectin
|
|
KR20120049214A
(ko)
|
2009-06-08 |
2012-05-16 |
악셀레론 파마 인코포레이티드 |
발열성 지방세포를 증가시키는 방법
|
|
KR20180026795A
(ko)
|
2009-06-12 |
2018-03-13 |
악셀레론 파마 인코포레이티드 |
절두된 ActRIIB-FC 융합 단백질
|
|
EP3202459B1
(en)
|
2009-09-09 |
2021-04-14 |
Acceleron Pharma Inc. |
Actriib antagonists and dosing and uses thereof for treating obesity or type 2 diabetes by regulating body fat content
|
|
AU2010315245B2
(en)
*
|
2009-11-03 |
2016-11-03 |
Acceleron Pharma Inc. |
Methods for treating fatty liver disease
|
|
EP3332796A1
(en)
|
2009-11-17 |
2018-06-13 |
Acceleron Pharma Inc. |
Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy
|
|
EP2402288B1
(en)
|
2010-07-02 |
2016-11-16 |
Alfa Laval Corporate AB |
Cleaning equipment for gas scrubber fluid
|
|
AU2011326586A1
(en)
|
2010-11-08 |
2013-05-30 |
Acceleron Pharma, Inc. |
ActRIIA binding agents and uses thereof
|
|
WO2012071559A2
(en)
|
2010-11-23 |
2012-05-31 |
Presage Biosciences, Inc. |
Therapeutic methods and compositions for solid delivery
|
|
CN113876945A
(zh)
|
2011-10-06 |
2022-01-04 |
免疫疫苗技术有限公司 |
包括激活或增加tlr2活性的佐剂的脂质体组合物及其应用
|
|
GR1007832B
(el)
*
|
2011-11-21 |
2013-02-14 |
Ιδρυμα Ιατροβιολογικων Ερευνων Ακαδημιας Αθηνων, |
Αδρανοποιητες της ακτιβινης και χρηση τους για την θεραπεια ασθενειων που σχετιζονται με παρεκκλινουσα ενεργοποιηση της "αμυντικης αποκρισης του ξενιστη"
|
|
EP2844271B1
(en)
*
|
2012-05-17 |
2018-02-28 |
Paranta Biosciences Limited |
Use of follistatin or of an activin inhibitor for preventing or treating tissue graft dysfunction
|
|
KR101704893B1
(ko)
|
2012-06-15 |
2017-02-08 |
화이자 인코포레이티드 |
Gdf-8에 대한 개선된 길항물질 항체 및 그의 용도
|
|
CN104968801B
(zh)
|
2012-10-24 |
2021-06-15 |
细胞基因公司 |
用于治疗贫血症的生物标志物
|
|
US10195249B2
(en)
|
2012-11-02 |
2019-02-05 |
Celgene Corporation |
Activin-ActRII antagonists and uses for treating bone and other disorders
|
|
EP3808778A1
(en)
|
2014-04-18 |
2021-04-21 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels and treating sickle-cell disease
|
|
CN114699529A
(zh)
|
2014-06-13 |
2022-07-05 |
阿塞勒隆制药公司 |
用于治疗溃疡的方法和组合物
|
|
CN104161959A
(zh)
*
|
2014-08-25 |
2014-11-26 |
山西藏象康寿科技有限公司 |
一种预防或治疗女性乳房不适症状的药食同源植物提取物制剂及制备方法
|
|
MA41052A
(fr)
|
2014-10-09 |
2017-08-15 |
Celgene Corp |
Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii
|
|
JP2018501307A
(ja)
|
2014-12-03 |
2018-01-18 |
セルジーン コーポレイション |
アクチビン−ActRIIアンタゴニスト及び貧血を治療するための使用
|
|
MA41119A
(fr)
|
2014-12-03 |
2017-10-10 |
Acceleron Pharma Inc |
Méthodes de traitement de syndromes myélodysplasiques et d'anémie sidéroblastique
|
|
JP2016131541A
(ja)
*
|
2015-01-20 |
2016-07-25 |
学校法人藤田学園 |
トランスジェニック非ヒト哺乳動物及びその用途
|
|
MA41919A
(fr)
|
2015-04-06 |
2018-02-13 |
Acceleron Pharma Inc |
Hétéromultimères alk4:actriib et leurs utilisations
|
|
MA41920B1
(fr)
|
2015-04-06 |
2021-05-31 |
Acceleron Pharma Inc |
Protéines de fusion de récepteur type i et type ii à bras unique et leurs utilisations
|
|
WO2017079591A2
(en)
|
2015-11-04 |
2017-05-11 |
Acceleron Pharma Inc. |
Methods for increasing red blood cell levels and treating ineffective erythropoiesis
|
|
EP3380121B1
(en)
|
2015-11-23 |
2023-12-20 |
Acceleron Pharma Inc. |
Actrii antagonist for use in treating eye disorders
|
|
WO2017177013A1
(en)
|
2016-04-06 |
2017-10-12 |
Acceleron Pharma Inc. |
Alk7 antagonists and uses thereof
|
|
DK3496739T3
(da)
|
2016-07-15 |
2021-05-10 |
Acceleron Pharma Inc |
Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension
|
|
MA45811A
(fr)
|
2016-07-27 |
2019-06-05 |
Acceleron Pharma Inc |
Méthodes et compositions de traitement de maladie.
|
|
CA3039074A1
(en)
|
2016-10-05 |
2018-04-12 |
Acceleron Pharma Inc. |
Compositions and method for treating kidney disease
|
|
CN115516100A
(zh)
|
2019-12-20 |
2022-12-23 |
全国儿童医院研究所 |
靶向肌肉疾病中肌肉的优化基因疗法
|
|
EP4698558A2
(en)
|
2023-04-18 |
2026-02-25 |
Research Institute at Nationwide Children's Hospital, Inc. |
Gene therapy for treating limb girdle muscular dystrophy r9 and congenital muscular dystrophy 1c
|
|
WO2025188993A2
(en)
|
2024-03-07 |
2025-09-12 |
Research Institute At Nationwide Children's Hospital |
Gene therapy for treating gne-related disorders
|